FDA Rules on Lab Developed Tests (LDTs)
The FDA's recent update on LDT regulations has raised questions about their implications for the biotech industry and the necessary adjustments for companies. We consulted Software QA Manager Ashwini Manjunath for insights into what these changes entail, particularly for small firms, and to share Strand’s experience with adapting laboratories to various global regulations.
Read our solution snapshot for more details.
Other
Resources
Poster
Decoding Ulcerative Colitis at the Cellular Level with our Single-Cell RNA Sequencing Data Curation Portal
Poster
Spatial Transcriptomics Workflow for Integrated Analysis and Precise Cell-type Annotations
Tech Note
Spatial Transcriptomics Data Analysis Pipeline for Research and Diagnostics
Download & Access
Our
Our
